Latest Vanderbilt University News | Page 2

Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid
YouTube More Likely to Direct Election-Fraud Videos to Users Already Skeptical about 2020 Election’s Legitimacy
Evusheld long-acting antibody combination approved for prevention and treatment of Covid in Japan
Researchers identify how cells move faster through mucus than blood
Australian Discovery in Sudden Cardiac Arrest Could Save Lives
Evusheld significantly prevented Covid disease progression or death in TACKLE Phase III treatment trial
Links between incentives and ethical lapses identified in ILR research
Evusheld significantly protected against symptomatic Covid for
Evusheld long-acting antibody combination approved in EU for pre-exposure prophylaxis of Covid in broad population
Evusheld long-acting antibody combination recommended for approval in EU for pre-exposure prophylaxis of Covid
AstraZeneca’s antibody combination, Evusheld▼ authorised for use
Researchers founding scientists of new GPCR biotechnology company launched with AUD$140 million in financing
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
Evusheld long-acting antibody combination authorised for emergency use
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
AZD7442 reduced risk of developing severe Covid or death in TACKLE Phase III outpatient treatment trial
AZD7442 request for Emergency Use Authorization for Covid prophylaxis filed in US
Study confirms spit testing may help doctors diagnose concussions
Yang-Tan Institute team studying autism and work outcomes
Having a family member locked up takes worse mental toll on African American women
Two pediatricians share Weill Cornell’s Drukier Prize
Atkinson COVID-19 grants could inform policy decisions